Efficacy and Safety of Tolperisone in Subjects With Pain Due to Acute Back Muscle Spasm
Clinical trial NCT04671082 · COMPLETED
Trial details
- NCT number
- NCT04671082
- Sponsor
- Neurana Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-15
- Primary completion
- 2021-12-13
- Enrollment
- 1004
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.